Search Results - "Geiges, G"

Quality of life of patients with hormone-dependent advanced prostate cancer receiving palliative treatment with Leuprorelin depot injection (Lutrate®) – interim results from a non-interventional study in Germany by Geiges, G., Winter, C., Katzenberger, K., Kübrich, M.

Get full text

UP-02.064 Safety and Efficacy of Degarelix in the Treatment of Prostate Cancer in a Cohort from a German Office-Based Registry for Uro-Oncological Quality Assurance by Geiges, G, Tolle, A, Schulze, M, Gedamke, M

Get full text

PCN120 Quality of Life Among German Patients With Metastatic Castration-Resistant Prostate Cancer by Wolff, J.M, Donatz, V, Klier, J, Erhardt, W, Dass, R.N., Dr, Geiges, G

Get full text

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Studies of a 1-month implant by Thyroff-Friesinger, U, Geiges, G, Engert, Z. Vendel

Get full text

A new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Clinical experience from a non-interventional study by Thyroff-Friesinger, U, Geiges, G, Engert, Z. Vendel

Get full text

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Pharmacokinetics of a 3-month implant by Thyroff-Friesinger, U, Geiges, G, Engert, Z. Vendel

Get full text

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Studies of a 3-month implant by Thyroff-Friesinger, U, Geiges, G, Engert, Z. Vendel

Get full text

Value of intermittent androgen deprivation in the context of the current data situation by Miller, K, Hammerer, P, Eichenauer, R, Geiges, G, Lehmann, J, Rodemer, G, Ruessel, C, Rulf, W, Suttmann, H, Wolff, J M

“…Androgen deprivation therapy is an integral part of the treatment of advanced and progressive prostate cancer. Various prospective randomised trials have…”
Get more information

838 Risk-adapted screening for bladder cancer: Daily routine in preventive care with the assessment tool RiskCheck Bladder Cancer© in the Urological Health-Service Research Association IQUO, Germany by Lüdecke, G, König, F, Geiges, G

Get full text

371 Preventive medical care in bladder cancer is possible: Risk-adapted screening in urology performed by IQUO-Germany by Lüdecke, G.C, Geiges, G, König, F

Get full text

What Patient Groups Have Special Benefits Using the GNRH-Antagonist Degarelix? Conclusions Based on Real Life Data from a German Registry by Geiges, G., Schulze, M., Gedamke, M.

Get full text

C99 PROVE OF PRINCIPLE BY HEALTH SERVICE RESEARCH OF THE GERMAN INSTITUTION IQUO FOR RISK-ADAPTED SCREENING IN BLADDER CANCER USING THE ONLINE-TOOL RISKCHECK BLADDER CANCER(c) (RCBC) by Lüdecke, G.C, Geiges, G, König, F

Get full text

Metastatic castration-resistant prostate cancer : Clinical data, new treatment options and therapy monitoring by Miller, K, Albers, P, Eichenauer, R, Geiges, G, Grimm, M-O, König, F, Mickisch, G, Pfister, D, Schwentner, C, Suttmann, H, Zastrow, S

“…Therapies currently available in Germany for metastatic castration-resistant prostate cancer (mCRPC) include docetaxel, cabazitaxel, abiraterone acetate,…”
Get full text

Interdisciplinary recommendations concerning the therapy for hormone-refractory prostatic carcinoma by Miller, K, Becker, K, Finke, F, Geiges, G, Göckel-Beining, B, Hossfeld, D K, Miller, K, Osieka, R, Rüssel, C, Tesch, H, Weissbach, L, Wirth, M, Wolff, J M

“…Therapy with Docetaxel for hormone-refractory prostatic carcinoma has for the first time led to an increase in the survival time. Docetaxel has become…”
Get more information

Metastatic castration-resistant prostate cancer: position paper for structured therapy monitoring by Miller, K, Albers, P, Eichenauer, R, Geiges, G, Grimm, M-O, König, F, Mickisch, G, Pfister, D, Schwentner, C, Suttmann, H, Zastrow, S

“…This position paper is intended to help to structure and to standardize therapy monitoring in patients with metastatic castration-resistant prostate cancer…”
Get full text

Metastasiertes kastrationsresistentes Prostatakarzinom: Aktuelle Daten, neue Therapieoptionen und strukturiertes Therapiemonitoring by Miller, K., Albers, P., Eichenauer, R., Geiges, G., Grimm, M.-O., König, F., Mickisch, G., Pfister, D., Schwentner, C., Suttmann, H., Zastrow, S.

“…Zusammenfassung Zur Behandlung des metastasierten kastrationsresistenten Prostatakarzinoms (mCRPC) stehen aktuell in Deutschland Docetaxel, Cabazitaxel,…”
Get full text

991 COMBINATION THERAPY WITH DUTASTERIDE PLUS TAMSULOSIN REDUCES MEDICAL RESOURCE UTILISATION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: 4-YEAR DATA FROM THE COMBAT STUDY by Montlleo, Gonzalez M, Geiges, G, Cicalese, V, Morrill, B, Black, L, Castro, R, Gagnier, P

Get full text

Metastasiertes kastrationsresistentes Prostatakarzinom: Positionspapier für ein strukturiertes Therapiemonitoring by Miller, K., Albers, P., Eichenauer, R., Geiges, G., Grimm, M.-O., König, F., Mickisch, G., Pfister, D., Schwentner, C., Suttmann, H., Zastrow, S.

“…Zusammenfassung Das vorliegende Positionspapier soll dazu beitragen, das Therapiemonitoring bei Patienten mit metastasiertem kastrationsresistentem…”
Get full text

Studienteilnahme in der urologischen Facharztpraxis by Geiges, G., Böhle, A., Rexer, H.

“…Die Beteiligung an klinischen Studien durch niedergelassene Facharztpraxen war in der Vergangenheit sehr selten. Die Gründe hierfür wurden in den letzten 10…”
Get full text

Study participation in urological specialty practices by Geiges, G, Böhle, A, Rexer, H

“…In the past, participation of practicing urologists in clinical trials has been very rare. The reasons for this have been influenced in different ways over the…”
Get full text